key: cord-0880630-bjw1483f
authors: Agarwal, Arnav; Basmaji, John; Fernando, Shannon M; Ge, Fang Zhou; Xiao, Yingqi; Faisal, Haseeb; Honarmand, Kimia; Hylands, Mathieu; Lau, Vincent I; Lewis, Kimberley; Couban, Rachel; Lamontagne, François; Adhikari, Neill KJ
title: Administration of Parenteral Vitamin C in Patients With Severe Infection: Protocol for a Systematic Review and Meta-analysis
date: 2022-01-06
journal: JMIR Res Protoc
DOI: 10.2196/33989
sha: 187ee8e26188a56f43a65a6a4faee726ab87439c
doc_id: 880630
cord_uid: bjw1483f

BACKGROUND: Severe infections are characterized by inflammation and oxidative damage. Ascorbic acid (vitamin C) administration may attenuate oxidative damage and, in turn, reduce vascular endothelial injury in pulmonary and systemic vasculature. OBJECTIVE: We aim to describe a protocol for a living systematic review that will evaluate the effectiveness and safety of parenteral vitamin C administration in adults with severe infections, including those with COVID-19. METHODS: We searched Ovid MEDLINE, Embase, CINAHL, the Centers for Disease Control and Prevention COVID-19 database, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from inception to March 30, 2021, for randomized controlled trials evaluating parenteral vitamin C versus no parenteral vitamin C in hospitalized adults with severe infection. Eligible studies will include at least 1 arm involving any dose of parenteral vitamin C alone or in combination with other cointerventions and at least 1 arm not involving parenteral vitamin C. The primary outcomes of interest will include in-hospital, 30-day, and 90-day mortality. Title and abstract screening, full-text screening, data extraction, and risk of bias evaluation via a modified Risk of Bias 2.0 tool will be conducted independently and in pairs. We will perform random effects modeling for meta-analyses, in which study weights will be generated by using the inverse variance method. We will assess certainty in effect estimates by using the Grading of Recommendations Assessment, Development and Evaluation methodology. Meta-analyses will be updated iteratively as new trial evidence becomes available. RESULTS: Among the 1386 citations identified as of March 30, 2021, a total of 17 eligible randomized controlled trials have been identified as of September 2021. We are in the process of updating the search strategy and associated data analyses. CONCLUSIONS: The results will be of importance to critical care physicians and hospitalists who manage severe infection and COVID-19 in daily practice, and they may directly inform international clinical guidance. Although our systematic review will incorporate the most recent trial evidence, ongoing trials may change our confidence in the estimates of effects, thereby necessitating iterative updates in the form of a living review. TRIAL REGISTRATION: PROSPERO CRD42020209187; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=209187 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/33989

S22 S17 AND S21 148 S21 S18 OR S19 OR S20 295,942 S20 TX (intravenous or parenteral* or enteral* or IV or infus* or transfus* or inject*) 295,930 S19 (MH "Administration, Intravenous+") 8,584 S18 (MH "Parenteral Nutrition+") 7,037 S17 S7 AND S16 434 S16 S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 313,921 S15 

$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or 40 (5111625) 42 (random$ adj sampl$ adj7 ("cross section$" or questionnaire$1 or survey$ or database$1)).ti,ab. not (comparative study/ or controlled study/ or randomi?

Systematic review not (trial or study)).ti. (151851) 46 (nonrandom$ not random$).ti,ab. (16349) 47 "Random field$".ti,ab. (2352) 48 (random cluster adj3 sampl$).ti,ab. (1302) 49 (review.ab. and review.pt.) not trial.ti. (823551) 50 "we searched".ab. and (review.ti. or review.pt.) (33158) 51 "update review".ab. (109) 52 (databases adj4 searched).ab. (37504) 53 (rat or rats or mouse or mice or swine or porcine or murine or sheep or lambs or pigs or piglets or rabbit or rabbits or cat or cats or dog or dogs or cattle or bovine or monkey or monkeys or trout or marmoset$1).ti. and animal experiment